COM:PHIOPHARMA
Phio Pharmaceuticals
- Stock
Last Close
2.53
22/11 21:00
Market Cap
2.61M
Beta: -
Volume Today
14.85K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||||||
average payables | 289.50K - | 224K 22.63% | 724K 223.21% | 1.04M 43.65% | 714K 31.35% | 530.50K 25.70% | 679.50K 28.09% | 768.50K 13.10% | 505.50K 34.22% | 531K 5.04% | 718K 35.22% | |
average receivables | ||||||||||||
book value per share | 27.76K - | 8.24K 70.31% | 8.98K 8.94% | 10.62K 18.28% | 535.96 94.95% | 1.27K 137.59% | 149.69 88.24% | 34.05 77.25% | 20.50 39.79% | 9.54 53.49% | 0.00 99.96% | |
capex per share | -438.20 - | -285.29 34.90% | -57.58 79.82% | -3.91 93.20% | -59.36 1,416.56% | -0.47 99.21% | -1.88 299.86% | -0.05 97.35% | -0.05 4.07% | -0.11 123.29% | -0.00 100.00% | |
capex to depreciation | -0.79 - | -1.09 38.59% | -0.74 32.21% | -0.08 89.80% | -2.90 3,742.50% | -0.06 97.87% | -1.07 1,640.90% | -0.26 75.44% | -0.68 157.68% | -0.63 7.80% | -0.03 95.67% | |
capex to operating cash flow | 0.01 - | 0.01 0.92% | 0.01 36.38% | 0.00 93.38% | 0.02 4,039.37% | 0.00 96.88% | 0.01 1,152.61% | 0.00 74.08% | 0.00 99.24% | 0.01 131.95% | 0.00 95.34% | |
capex to revenue | -0.20 - | -1.34 584.45% | -1.68 25.29% | -0.21 87.44% | -13.53 6,328.33% | -0.04 99.73% | -3.43 9,362.86% | |||||
cash per share | 80.84K - | 25.51K 68.44% | 10.72K 57.97% | 12.63K 17.75% | 1.05K 91.71% | 1.40K 33.27% | 180.57 87.06% | 37.26 79.37% | 22.49 39.64% | 10.37 53.91% | 0.00 99.96% | |
days of inventory on hand | ||||||||||||
days payables outstanding | 1.90K - | |||||||||||
days sales outstanding | ||||||||||||
debt to assets | 0.11 - | 0.06 - | 0.04 36.70% | 0.01 71.27% | 0.02 103.08% | 0.00 84.30% | ||||||
debt to equity | 0.36 - | 0.09 - | 0.05 45.27% | 0.01 72.73% | 0.03 109.22% | 0.00 83.91% | ||||||
dividend yield | 0.12 - | 0.01 92.87% | 0.00 - | 0.33 143,436.74% | ||||||||
earnings yield | -0.61 - | -0.25 59.26% | -0.41 63.67% | -1.86 355.32% | -0.99 46.80% | -3.17 219.41% | -2.04 35.63% | -0.71 65.07% | -1.03 44.43% | -2.23 116.67% | -0.01 99.69% | |
enterprise value | 22.68M - | 26.67M 17.59% | 19.84M 25.60% | -8.08M 140.74% | 8.97M 210.96% | -12.56M 240.00% | -2.08M 83.42% | -1.26M 39.39% | -10.93M 765.73% | -6.41M 41.36% | 1.58B 24,683.71% | |
enterprise value over ebitda | -1.09 - | -3.02 177.51% | -1.94 35.77% | 0.89 146.14% | -1.93 315.20% | 1.71 188.57% | 0.23 86.41% | 0.14 37.54% | 0.81 458.81% | 0.56 30.88% | -145.52 26,132.75% | |
ev to operating cash flow | -3.59 - | -3.44 4.34% | -2.71 21.11% | 1.04 138.41% | -0.94 190.50% | 1.67 277.12% | 0.24 85.58% | 0.14 40.47% | 0.92 542.62% | 0.53 42.67% | -146.53 27,839.86% | |
ev to sales | 56.84 - | 375.62 560.83% | 583.61 55.37% | -425.43 172.90% | 597.94 240.55% | -90.99 115.22% | -99.15 8.97% | |||||
free cash flow per share | -35.89K - | -23.58K 34.30% | -7.45K 68.42% | -7.60K 1.99% | -2.84K 62.60% | -705.71 75.16% | -227.01 67.83% | -23.07 89.84% | -11.13 51.75% | -10.78 3.19% | -0.01 99.95% | |
free cash flow yield | -0.19 - | -0.22 19.08% | -0.30 32.29% | -1.61 444.91% | -0.77 51.90% | -3.24 318.49% | -2.01 37.92% | -0.71 64.46% | -0.93 29.79% | -2.42 160.47% | -0.01 99.72% | |
graham net net | 24.69K - | 6.16K 75.04% | 8.43K 36.84% | 10.14K 20.26% | 384.80 96.21% | 1.23K 220.13% | 120.91 90.18% | 30.14 75.07% | 19.46 35.42% | 8.63 55.68% | 0.00 99.96% | |
graham number | 270.99K - | 70.01K 74.17% | 45.68K 34.76% | 45.86K 0.40% | 6.63K 85.55% | 4.45K 32.89% | 880.58 80.20% | 132.76 84.92% | 75.49 43.14% | 46.20 38.80% | 0.02 99.95% | |
income quality | 0.30 - | 0.88 192.30% | 0.72 18.81% | 0.86 20.55% | 0.76 11.44% | 1.02 33.73% | 0.97 5.02% | 1.00 3.14% | 0.89 10.84% | 1.06 18.39% | 0.99 6.02% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -872.88 - | 14.06K - | 1.50K - | 65.50 95.64% | ||||||||
interest debt per share | 134.83 - | 2.99K 2,120.55% | -0.29 - | 13.49 - | 1.68 87.55% | 0.27 84.08% | 0.11 57.22% | 0.00 99.99% | ||||
inventory turnover | ||||||||||||
invested capital | 0.36 - | 0.09 - | 0.05 45.27% | 0.01 72.73% | 0.03 109.22% | 0.00 83.91% | ||||||
market cap | 34.07M - | 35.16M 3.22% | 24.96M 29.02% | 4.82M 80.68% | 12.55M 160.22% | 2.32M 81.49% | 4.33M 86.61% | 12.34M 184.74% | 12.84M 4.02% | 5.07M 60.51% | 1.58B 31,138.63% | |
net current asset value | 4.75M - | 2.54M 46.41% | 8.71M 242.33% | 10.56M 21.30% | 1.57M 85.17% | 13.41M 755.52% | 5.01M 62.64% | 12.44M 148.39% | 21.49M 72.71% | 10.47M 51.28% | 7.69M 26.57% | |
net debt to ebitda | 0.55 - | 0.96 76.03% | 0.50 48.01% | 1.43 185.69% | 0.77 46.19% | 2.02 162.87% | 0.71 64.67% | 1.56 118.47% | 1.76 12.76% | 1.00 43.07% | 0.78 21.98% | |
net income per share | -117.56K - | -26.43K 77.52% | -10.33K 60.92% | -8.80K 14.78% | -3.64K 58.63% | -690.24 81.04% | -230.23 66.64% | -23.00 90.01% | -12.35 46.31% | -9.95 19.47% | -0.01 99.95% | |
operating cash flow per share | -35.46K - | -23.30K 34.29% | -7.39K 68.28% | -7.59K 2.73% | -2.78K 63.36% | -705.24 74.65% | -225.13 68.08% | -23.03 89.77% | -11.09 51.85% | -10.67 3.74% | -0.01 99.95% | |
payables turnover | 0.19 - | |||||||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | 44.24 - | 80 80.84% | 203.68 154.60% | 285 39.93% | 358 25.61% | 31.35 91.24% | 204.76 553.19% | |||||
return on tangible assets | -1.40 - | -0.96 31.63% | -0.92 4.34% | -0.67 26.72% | -3.04 352.61% | -0.48 84.19% | -1.10 128.95% | -0.56 49.19% | -0.52 6.05% | -0.88 68.07% | -1.16 31.05% | |
revenue per share | 2.24K - | 213.21 90.49% | 34.34 83.89% | 18.59 45.87% | 4.39 76.41% | 12.94 195.08% | 0.55 95.77% | |||||
roe | -4.23 - | -3.21 24.29% | -1.15 64.13% | -0.83 27.95% | -6.79 719.89% | -0.54 92.02% | -1.54 183.75% | -0.68 56.08% | -0.60 10.83% | -1.04 73.15% | -1.40 34.27% | |
roic | -4.24 - | -2.33 45.07% | -1.14 50.98% | -0.82 27.83% | -6.79 724.12% | -0.54 92.01% | -1.31 142.29% | -0.62 52.47% | -0.60 4.55% | -1.00 67.26% | -1.39 39.09% | |
sales general and administrative to revenue | 9.27 - | 45.31 389.01% | 98.41 117.20% | 190.47 93.55% | 267.40 40.39% | 23.01 91.39% | 224.19 874.13% | |||||
shareholders equity per share | 27.76K - | 8.24K 70.31% | 8.98K 8.94% | 10.62K 18.28% | 535.96 94.95% | 1.27K 137.59% | 149.69 88.24% | 34.05 77.25% | 20.50 39.79% | 9.54 53.49% | 0.00 99.96% | |
stock based compensation to revenue | 4.96 - | 26 424.20% | 45.15 73.64% | 39.79 11.87% | 20.93 47.39% | 2.04 90.24% | 14.29 599.09% | |||||
tangible asset value | 4.94M - | 2.75M 44.46% | 8.89M 223.86% | 10.86M 22.10% | 1.83M 83.11% | 13.58M 640.75% | 5.75M 57.67% | 13.02M 126.46% | 21.93M 68.49% | 10.84M 50.58% | 7.73M 28.68% | |
tangible book value per share | 27.76K - | 8.24K 70.31% | 8.98K 8.94% | 10.62K 18.28% | 535.96 94.95% | 1.27K 137.59% | 149.69 88.24% | 34.05 77.25% | 20.50 39.79% | 9.54 53.49% | 0.00 99.96% | |
working capital | 12.67M - | 7.65M 39.58% | 8.71M 13.78% | 10.56M 21.30% | 1.57M 85.17% | 13.41M 755.52% | 5.42M 59.57% | 12.97M 139.26% | 21.66M 67.02% | 10.64M 50.87% | 7.69M 27.76% |
All numbers in (except ratios and percentages)